Last reviewed · How we verify
Ménière's disease
Approved treatments
- Merislon
Merislon works by binding to the histamine H3 receptor, which helps to regulate the balance of fluids in the inner ear. - Pyridylcarbinol
Pyridylcarbinol works by providing the body with a precursor to NAD+, a crucial coenzyme involved in energy metabolism. - Merislon · Zhan Yunfan
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ménière's disease patent landscape — cliff calendar, originator estates, attackable patents
- Ménière's disease treatment landscape brief
- Ménière's disease treatment updates RSS
Frequently asked questions about Ménière's disease
What drugs treat Ménière's disease?
Tracked treatments include Merislon, Pyridylcarbinol.
What is the treatment for Ménière's disease?
Standard treatment for Ménière's disease includes Merislon, Pyridylcarbinol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ménière's disease patent cliff · Ménière's disease CI report
- Treatment: Merislon
- Treatment: Pyridylcarbinol
- Treatment: Merislon · Zhan Yunfan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing